keyword
https://read.qxmd.com/read/38646499/advances-in-molecular-mechanisms-of-inflammatory-bowel-disease%C3%A2-associated-colorectal-cancer-review
#1
REVIEW
Zhi Wang, Yu Chang, Haibo Sun, Yuqin Li, Tongyu Tang
The link between inflammation and cancer is well documented and colonic inflammation caused by inflammatory bowel disease (IBD) is thought to be a high-risk factor for the development of colorectal cancer (CRC). The complex crosstalk between epithelial and inflammatory cells is thought to underlie the progression from inflammation to cancer. The present review collates and summarises recent advances in the understanding of the pathogenesis of IBD-associated CRC (IBD-CRC), including the oncogenic mechanisms of the main inflammatory signalling pathways and genetic alterations induced by oxidative stress during colonic inflammation, and discusses the crosstalk between the tumour microenvironment, intestinal flora and host immune factors during inflammatory oncogenesis in colitis-associated CRC...
June 2024: Oncology Letters
https://read.qxmd.com/read/38546105/nonconventional-dysplasia-is-frequently-associated-with-goblet-cell-deficient-and-serrated-variants-of-colonic-adenocarcinoma-in-inflammatory-bowel-disease
#2
JOURNAL ARTICLE
Andrew Xiao, Masato Yozu, Bence P Kővári, Lindsay Yassan, Xiaoyan Liao, Marcela Salomao, Maria Westerhoff, Anita Sejben, Gregory Y Lauwers, Won-Tak Choi
Various subtypes of nonconventional dysplasia have been recently described in inflammatory bowel disease (IBD). We hypothesized that goblet cell deficient dysplasia and serrated dysplasia may be the primary precursor lesions for goblet cell deficient (GCDAC) and serrated (SAC) variants of colonic adenocarcinoma, respectively. Clinicopathologic features of 23 GCDAC and 10 SAC colectomy cases were analyzed. All dysplastic lesions found adjacent to the colorectal cancers (n = 22 for GCDACs and n = 10 for SACs) were subtyped as conventional, nonconventional, or mixed-type dysplasia...
March 27, 2024: American Journal of Surgical Pathology
https://read.qxmd.com/read/38529274/comparative-analysis-of-single-cell-transcriptome-reveals-heterogeneity-and-commonality-in-the-immune-microenvironment-of-colorectal-cancer-and-inflammatory-bowel-disease
#3
JOURNAL ARTICLE
Hongchao Lv, Yu Mu, Chen Zhang, Meiqi Zhao, Ping Jiang, Shan Xiao, Haiming Sun, Nan Wu, Donglin Sun, Yan Jin
BACKGROUND: During aging, chronic inflammation can promote tumor development and metastasis. Patients with chronic inflammatory bowel diseases (IBD) are at an increased risk of developing colorectal cancer (CRC). However, the molecular mechanism underlying is still unclear. METHODS: We conducted a large-scale single-cell sequencing analysis comprising 432,314 single cells from 92 CRC and 24 IBD patients. The analysis focused on the heterogeneity and commonality of CRC and IBD with respect to immune cell landscape, cellular communication, aging and inflammatory response, and Meta programs...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38527929/perioperative-outcomes-of-ileorectal-anastomosis-an-analysis-of-823-patients
#4
JOURNAL ARTICLE
Adam Truong, Katherine Hu, David Liska, Michael Valente, Tracy Hull, Scott R Steele, Stefan D Holubar
AIM: Ileorectal anastomosis (IRA) following total abdominal colectomy (TAC) allows for resortation of bowel continuity but prior studies have reported rates of anastomotic leak (AL) to be as high as 23%. We aimed to report rates of AL and complications in a large cohort of patients undergoing IRA. We hypothesized that AL rates were lower than previously reported and that selective use of diverting loop ileostomy (DLI) is associated with decreased AL rates. METHOD: Patients undergoing TAC or end-ileostomy reversal with IRA, with or without DLI, between 1980 and 2021 were identified from a prospectively maintained institutional database and retrospectively analysed...
March 25, 2024: Colorectal Disease
https://read.qxmd.com/read/38523892/impact-of-various-risk-factors-on-the-positive-fecal-immunochemical-test-for-colorectal-cancer-in-the-iranian-population
#5
JOURNAL ARTICLE
Nasrin Milani, Tayyebeh Jalayernia Darband, Ehsan Mousa-Farkhani, Ladan Goshayeshi, Mona Kabiri
Background: Colorectal cancer (CRC) is the most prevalent cancer with high mortality worldwide. We aimed to evaluate the incidence of CRC based on the positive fecal immunochemical test (FIT) result in the Iranian population. Methods: The present study was conducted on the health assessment data recorded in the SINA (Integrated Health Information System) in 2018 and 2019 from individuals who had participated in the national program, including asymptomatic people aged 50-69 years or had risk factors of CRC such as family or past personal history of CRC as well as symptomatic individuals, for the early detection and prevention of CRC in Mashhad, Iran...
October 2023: Middle East Journal of Digestive Diseases
https://read.qxmd.com/read/38516408/ercc4-a-potential-regulatory-factor-in-inflammatory-bowel-disease-and-inflammation-associated-colorectal-cancer
#6
REVIEW
Runjie Shi, Shanping Wang, Ying Jiang, Guoqiang Zhong, Mingsong Li, Yan Sun
The pathogenesis of inflammatory bowel disease (IBD) remains unclear and is associated with an increased risk of developing colitis-associated cancer (CAC). Under sustained inflammatory stimulation in the intestines, loss of early DNA damage response genes can lead to tumor formation. Many proteins are involved in the pathways of DNA damage response and play critical roles in protecting genes from various potential damages that DNA may undergo. ERCC4 is a structure-specific endonuclease that participates in the nucleotide excision repair (NER) pathway...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38514581/role-of-ph-sensing-receptors-in-colitis
#7
REVIEW
Martin Hausmann, Klaus Seuwen, Cheryl de Vallière, Moana Busch, Pedro A Ruiz, Gerhard Rogler
Low pH in the gut is associated with severe inflammation, fibrosis, and colorectal cancer (CRC) and is a hallmark of active inflammatory bowel disease (IBD). Subsequently, pH-sensing mechanisms are of interest for the understanding of IBD pathophysiology. Tissue hypoxia and acidosis-two contributing factors to disease pathophysiology-are linked to IBD, and understanding their interplay is highly relevant for the development of new therapeutic options. One member of the proton-sensing G protein-coupled receptor (GPCR) family, GPR65 (T-cell death-associated gene 8, TDAG8), was identified as a susceptibility gene for IBD in a large genome-wide association study...
March 22, 2024: Pflügers Archiv: European Journal of Physiology
https://read.qxmd.com/read/38507548/specific-deletion-of-mettl3-in-iecs-triggers-the-development-of-spontaneous-colitis-and-dysbiosis-of-t-lymphocytes-in-mice
#8
JOURNAL ARTICLE
Miao Fang, Jie Yao, Haifeng Zhang, Jiahui Sun, Yiping Yin, Hongzhou Shi, Guangqing Jiang, Xin Shi
The enzymatic core component of m6A writer complex, Mettl3, plays a crucial role in facilitating the development and progress in gastric and colorectal cancer (CRC). However, its underlying mechanism in regulating intestinal inflammation remains unclear and poorly investigated. Firstly, the characteristics of Mettl3 expression in IBD patients were examined. Afterwards we generated the mice line with IECs-specific deletion of Mettl3 verified by various experiments. We continuously recorded and compared the physiological status including survival rate etc...
March 20, 2024: Clinical and Experimental Immunology
https://read.qxmd.com/read/38505585/digital-spatial-profiling-identifies-molecular-changes-involved-in-development-of-colitis-associated-colorectal-cancer
#9
JOURNAL ARTICLE
Tamara Glyn, Sarah Williams, Martin Whitehead, Tim Eglinton, Nicholas West, Rachel V Purcell
OBJECTIVE: Chronic colonic inflammation seen in inflammatory bowel disease (IBD) is a risk factor for colorectal cancer (CRC). Colitis-associated cancers (CAC) are molecularly different from sporadic CRC. This study aimed to evaluate spatially defined molecular changes associated with neoplastic progression to identify mechanisms of action and potential biomarkers for prognostication. DESIGN: IBD patients who had undergone colectomy for treatment of their IBD or dysplasia were identified from an institutional database...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38440826/protease-activated-receptor-2-drives-migration-in-a-colon-cancer-cell-line-but-not-in-non-cancerous-human-epithelial-cells
#10
JOURNAL ARTICLE
Larissa Lucena Périco, Andrew J Vegso, Cristiane H Baggio, Wallace K MacNaughton
The inflamed mucosa contains a complex assortment of proteases which may participate in wound healing or in the development of inflammation-associated colon cancer. We sought to determine the role of protease-activated receptor 2 (PAR2) in epithelial wound healing in both untransformed and transformed colonic epithelial cells. Monolayers of primary epithelial cells derived from organoids cultivated from patient colonic biopsies, and of the T84 colon cancer cell line, were grown to confluence, wounded in the presence of a selective PAR2-activating peptide, and healing visualized by live cell microscopy...
March 5, 2024: American Journal of Physiology. Gastrointestinal and Liver Physiology
https://read.qxmd.com/read/38433657/the-clinical-and-economic-burden-of-illness-in-the-first-two-years-after-ostomy-creation-a-nationwide-danish-cohort-study
#11
JOURNAL ARTICLE
Frederikke Bruun Andersen, Jakob Kjellberg, Rikke Ibsen, Catarina Sternhufvud, Birte Petersen
BACKGROUND: Living with an ostomy is often associated with costly complications. This study examined the burden of illness the first two years after ostomy creation. METHODS: Data from Danish national registries included all adult Danes with an ostomy created between 2002-2014. RESULTS: Four cohorts consisted respectively of 11,385 subjects with a colostomy and 4,574 with an ileostomy, of which 1,663 subjects had inflammatory bowel disease (IBD) and 1,270 colorectal cancer as cause of their ileostomy...
March 4, 2024: Expert Review of Pharmacoeconomics & Outcomes Research
https://read.qxmd.com/read/38428656/anchang-yuyang-decoction-inhibits-experimental-colitis-related-carcinogenesis-by-regulating-ppar-signaling-pathway-and-affecting-metabolic-homeostasis-of-host-and-microbiota
#12
JOURNAL ARTICLE
Xiunan Wei, Junwei Liang, Jiahui Liu, Yonggang Dai, Xiaohui Leng, Yan Cheng, Lili Chi
ETHNOPHARMACOLOGICAL RELEVANCE: Inflammatory bowel disease (IBD) presents a risk of carcinogenesis, which escalates with the duration of IBD. Persistent histological inflammation is considered to be the driving factor of colitis carcinogenesis. Effective control of inflammation is helpful to prevent and treat colitis-related colorectal cancer (CAC). Anchang Yuyang Decoction (AYD), a traditional Chinese medicine (TCM) formula, is originated from the ancient prescription of TCM for treating colitis and colorectal cancer...
February 28, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38419394/risk-of-colorectal-cancer-in-patients-with-primary-sclerosing-cholangitis-and-concomitant-inflammatory-bowel-disease-compared-with-primary-sclerosing-cholangitis-only
#13
JOURNAL ARTICLE
Taranika Sarkar Das, Kimberly Ho, Jahnavi Udaikumar, Bryan Chen, Olivia Delau, Aasma Shaukat, Ira Jacobson, Raiya Sarwar
AIM: Primary sclerosing cholangitis (PSC) increases the risk of colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients; however, there is a paucity of literature to suggest PSC alone as an independent risk factor for CRC. We aimed to determine if PSC is an independent risk factor for CRC in a large tertiary care medical center. Optimizing screening intervals is of great importance, given the burden and risks associated with a lifetime of colonoscopy screening. METHODS: This retrospective cohort study consists of patients diagnosed with PSC preceding IBD (PSC-IBD) and PSC-only before January 6, 2023 from a large, tertiary, academic medical center...
February 28, 2024: Hepatology Research: the Official Journal of the Japan Society of Hepatology
https://read.qxmd.com/read/38415550/tlr4-iga-and-epcam-expression-in-colorectal-cancer-and-their-possible-association-with-microbiota-as-a-pathogenic-factor-an-immunohistochemical-and-genetic-study
#14
JOURNAL ARTICLE
Fatma S Hafez, Marwa M Shakweer, Dina Sabry, Amany M Tawfik, Shaimaa Mohsen El-Beah, Nadia M Elsheshtawy, Lobna S Shash, Doaa E A Salama, Ahmed Gaballah
BACKGROUND: The pathogenesis of inflammatory bowel disease (IBD) and colorectal cancer (CRC) is thought to be related to immune response against gut microbiota. TLR4, IgA, and EpCAM have a role in intestinal local immune response and their altered expression related to both IBD and CRC. Lipopolysaccharide (LPS) is the main activator of TLR4. The objective of this study is to evaluate the possible role of intestinal microbiota in the pathogenesis of IBD and CRC through expression of TLR4, IgA and EpCAM...
February 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38407208/risk-of-malignancy-in-a-high-incidence-population-based-cohort-of-faroese-patients-with-inflammatory-bowel-disease-from-1960-to-2020-a-faroese-ibd-cohort-study
#15
JOURNAL ARTICLE
Jóngerð Midjord, Kári Rubek Nielsen, Amanda Gratton Vang, Marin Strøm, Søren Lophaven, Turid Hammer, Johan Burisch
BACKGROUND: The association between inflammatory bowel disease (IBD) and malignancy remains disputed despite many observational studies. The Faroese population exhibits the highest occurrence of IBD in the world. This study aimed to investigate the cancer risk in Faroese IBD patients in a nationwide IBD cohort. METHODS: This study included all IBD patients diagnosed in the Faroe Islands between 1960 and 2020. Clinical demographics and cancer diagnoses were retrieved from patient files and the Faroese cancer registry...
February 26, 2024: Scandinavian Journal of Gastroenterology
https://read.qxmd.com/read/38405748/accessible-chromatin-maps-of-inflammatory-bowel-disease-intestine-nominate-cell-type-mediators-of-genetic-disease-risk
#16
Joseph A Wayman, Zi Yang, Elizabeth Angerman, Erin Bonkowski, Ingrid Jurickova, Xiaoting Chen, Anthony T Bejjani, Lois Parks, Sreeja Parameswaran, Alexander G Miethke, Kelli L VanDussen, Jasbir Dhaliwal, Matthew T Weirauch, Leah C Kottyan, Lee A Denson, Emily R Miraldi
Inflammatory Bowel Disease ( IBD ) is a chronic and often debilitating autoinflammatory condition, with an increasing incidence in children. Standard-of-care therapies lead to sustained transmural healing and clinical remission in fewer than one-third of patients. For children, TNFα inhibition remains the only FDA-approved biologic therapy, providing an even greater urgency to understanding mechanisms of response. Genome-wide association studies ( GWAS ) have identified 418 independent genetic risk loci contributing to IBD, yet the majority are noncoding and their mechanisms of action are difficult to decipher...
February 13, 2024: bioRxiv
https://read.qxmd.com/read/38398179/therapeutic-potential-for-sphingolipids-in-inflammatory-bowel-disease-and-colorectal-cancer
#17
REVIEW
Keila S Espinoza, Ashley J Snider
Inflammatory bowel disease (IBD), characterized by chronic inflammation in the intestinal tract, increases the risk for the development of colorectal cancer (CRC). Sphingolipids, which have been implicated in IBD and CRC, are a class of bioactive lipids that regulate cell signaling, differentiation, apoptosis, inflammation, and survival. The balance between ceramide (Cer), the central sphingolipid involved in apoptosis and differentiation, and sphingosine-1-phosphate (S1P), a potent signaling molecule involved in proliferation and inflammation, is vital for the maintenance of normal cellular function...
February 15, 2024: Cancers
https://read.qxmd.com/read/38383742/clinical-factors-associated-with-severity-in-patients-with-inflammatory-bowel-disease-in-brazil-based-on-2-year-national-registry-data-from-gediib
#18
JOURNAL ARTICLE
Renata de Sá Brito Fróes, Adriana Ribas Andrade, Mikaell Alexandre Gouvea Faria, Heitor Siffert Pereira de Souza, Rogério Serafim Parra, Cyrla Zaltman, Carlos Henrique Marques Dos Santos, Mauro Bafutto, Abel Botelho Quaresma, Genoile Oliveira Santana, Rafael Luís Luporini, Sérgio Figueiredo de Lima Junior, Sender Jankiel Miszputen, Mardem Machado de Souza, Giedre Soares Prates Herrerias, Roberto Luiz Kaiser Junior, Catiane Rios do Nascimento, Omar Féres, Jaqueline Ribeiro de Barros, Ligia Yukie Sassaki, Rogerio Saad-Hossne
The Brazilian Organization for Crohn's Disease and Colitis (GEDIIB) established a national registry of inflammatory bowel disease (IBD). The aim of the study was to identify clinical factors associated with disease severity in IBD patients in Brazil. A population-based risk model aimed at stratifying the severity of IBD based on previous hospitalization, use of biologics, and need for surgery for ulcerative colitis (UC) and Crohn's Disease (CD) and on previous complications for CD. A total of 1179 patients (34...
February 21, 2024: Scientific Reports
https://read.qxmd.com/read/38368773/mineralocorticoid-promotes-intestinal-inflammation-through-receptor-dependent-il17-production-in-ilc3s
#19
JOURNAL ARTICLE
Rongchuan Zhao, Lei Hong, Guohua Shi, Hong Ye, Xinqi Lou, Xinying Zhou, Jinyu Yao, Xiaohua Shi, Jianzhong An, Minxuan Sun
Aldosterone is a key mineralocorticoid involved in regulating the concentration of blood electrolytes and physiological volume balance. Activation of mineralocorticoid receptor (MR) has been recently reported to participate in adaptive and innate immune responses under inflammation. Here, we evaluated the role of aldosterone and MR in inflammation bowel diseases (IBD). Aldosterone elevated in the colon of DSS-induced colitis mice. Aldosterone addition induced IL17 production and ROS/RNS level in group 3 innate lymphoid cells (ILC3s) and exacerbated intestinal injury...
February 17, 2024: International Immunopharmacology
https://read.qxmd.com/read/38354883/pesticide-use-and-inflammatory-bowel-disease-in-licensed-pesticide-applicators-and-spouses-in-the-agricultural-health-study
#20
JOURNAL ARTICLE
Dazhe Chen, Christine G Parks, Jonathan N Hofmann, Laura E Beane Freeman, Dale P Sandler
BACKGROUND: Pesticide exposure has been linked to some autoimmune diseases and colorectal cancer, possibly via alteration of gut microbiota or other mechanisms. While pesticides have been linked to gut dysbiosis and inflammation in animal models, few epidemiologic studies have examined pesticides in relation to inflammatory bowel disease (IBD). OBJECTIVES: We evaluated use of pesticides and incident IBD in 68,480 eligible pesticide applicators and spouses enrolled in the Agricultural Health Study...
February 12, 2024: Environmental Research
keyword
keyword
12051
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.